Health
A case report on two patients with multiple sclerosis has sparked hope, caution, and calls to expand the limited research data on ibogaine as a possible treatment for MS.
In the second part of our two-part interview with Dr. Howard Kornfeld, Ann Harrison asks the addiction treatment expert about ketamine dependency.
In the first part of a two-part series, Ann Harrison interviews addiction treatment expert Dr. Howard Kornfeld about the FDA decision to reject the Lykos Therapeutics proposal for MDMA-assisted therapy.
Can post-market surveillance ensure the safety of psychedelic therapies?
A new report shows ER visits and hospitalizations associated with psychedelic use in California are up, but the reasons are unclear.
An all-volunteer corps of over 400 medical professionals organized to help the Tribe of Nova festival survivors begin to heal, with an emphasis on rapid response.
A forthcoming study that examines the impact of psychedelics on religious clergy appears to support earlier findings about the nature and persistence of mystical experiences.
A conversation with the eminent scientist Roland Griffiths about the importance of studying psychedelics and transformative experiences.
A research partnership between the University of California San Francisco and the Fireside Project peer-support hotline reveals insights into psychedelic harm reduction.
MDMA and LSD may be a beneficial combination for patients who have never taken psychedelics and are frightened, suggests one researcher.
